Full-Time

Medical Director

Michigan Market

Daymark Health

Daymark Health

51-200 employees

Value-based oncology care with home-based support

No salary listed

Detroit, MI, USA

Hybrid

Hybrid role combining in-person and virtual care.

MD

Category
Medical, Clinical & Veterinary (1)

Get referred to Daymark Health

See people who can refer or advise you

Requirements
  • Board certification as a physician in medical, radiation, or surgical oncology, or a closely related specialty.
  • An MD or DO degree.
  • An active, unrestricted Michigan medical license, or willingness to obtain one.
  • At least 5 years of oncology practice experience, including direct patient care.
  • Experience leading or supervising clinical teams.
  • Familiarity with palliative care and interest in becoming board certified in palliative care if not already certified.
  • Experience with, or a strong interest in, value-based and/or virtual and at-home models of cancer care.
  • Familiarity with oncology value-based payment models such as the Oncology Care Model and Enhancing Oncology Model.
  • Ability to partner effectively with an operational counterpart and share accountability for outcomes.
  • Ability to use clinical and operational data to monitor outcomes, identify gaps, and drive continuous improvement.
  • Ability to communicate effectively with cross-functional teams, health plan partners, and provider partners.
  • Comfort with technology and the ability to learn new systems and tools.
Responsibilities
  • Serve as the senior clinical leader for the Michigan market and set the clinical vision and standard of care for regional cancer patients.
  • Partner with the Market Operations Leader in a dyad leadership model to combine clinical expertise and operational excellence.
  • Launch Daymark’s Michigan market alongside the VP of Market Operations and COO.
  • Establish and hold the team accountable to market-level clinical, quality, enrollment, patient-experience, and other key performance indicators.
  • Share accountability for how the clinical model drives financial performance, including total-cost-of-care savings and reductions in avoidable acute-care utilization.
  • Collaborate on hiring, team management, and day-to-day operational leadership to develop a high-performing team.
  • Uphold the care model and quality standards for the Michigan market.
  • Serve as the collaborating physician of record for the market’s Nurse Practitioners in accordance with Michigan requirements.
  • Provide clinical oversight and supervision for other clinical staff.
  • Directly manage one to two market-based physicians.
  • Provide direct supportive oncology patient care, second opinions, clinical trial advisory, and documentation-integrity support for up to 20% of the role.
  • Support complex or high-acuity patients and clinical escalations.
  • Participate in remote supportive oncology on-call coverage as needed.
  • Partner with national leadership to refine and continuously improve the care model.
  • Contribute clinical expertise to the design of new programs, processes, and clinical workflows.
  • Serve as the senior clinical representative to oncology practices, primary care physicians, health systems, and health plan partners in Michigan.
  • Represent Daymark in clinical case conferences and joint operating meetings with provider and payer partners.
Desired Qualifications
  • Interest in becoming board certified in palliative care if not already certified.
  • Strong interest in value-based and/or virtual and at-home models of cancer care.

Daymark Health partners with health plans to take on total cost of care risk and provides supplementary cancer care through in-home and virtual services. Its platform blends care navigation, 24/7 support, symptom management, and early palliative care via a twice-weekly symptom tool, delivered by a community team of nurse practitioners, nurses, social workers, and Health Partners. The model is tied to payer contracts and aims to keep patients outside traditional clinics, reducing fragmentation and coordinating care across the health system. The goal is to improve patient outcomes while lowering overall costs for payers and patients, addressing the needs of the roughly two million Americans diagnosed with cancer each year.

Company Size

51-200

Company Stage

Series A

Total Funding

$31.5M

Headquarters

Nashville, Tennessee

Founded

2024

Get referred to Daymark Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BCBSRI publicly expanded Daymark’s program on October 5, 2025, validating payer demand.
  • Daymark raised $20 million on September 25, 2025, extending runway for national expansion.
  • Daymark won the Platinum Pinnacle Award in May 2026, signaling strong patient-experience execution.

What critics are saying

  • Thyme Care raised $125 million on September 2, 2026, intensifying buyer attention and pricing pressure.
  • Daymark’s model depends on a few payer contracts, especially BCBSRI’s 2,500-member launch.
  • Full-risk oncology contracting can implode in one bad utilization cycle, killing the company.

What makes Daymark Health unique

  • Justin Bekelman’s oncology pedigree anchors Daymark’s clinical model and payer strategy.
  • Daymark combines in-home visits, virtual support, and palliative care for cancer patients.
  • The February 2026 advisory board adds MSK, Penn, Optum, Humana, and VA veterans.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

Flexible Work Hours

Hybrid Work Options

Wellness Program

Mental Health Support

Phone/Internet Stipend

Professional Development Budget

Conference Attendance Budget

Growth & Insights and Company News

Headcount

6 month growth

24%

1 year growth

24%

2 year growth

41%
Axios
Sep 25th, 2025
Pro Rata Premium: First Look

| Inspiren, a New York-based senior living technology company, raised a $100m Series B led by Insight Partners.

Boone Newspapers Inc.
Sep 25th, 2025
Daymark Health Raises $20M in Series A Funding to Scale Tech-Enabled Cancer Care Platform to Thousands of Patients

PHILADELPHIA, Sept. 25, 2025 /PRNewswire/ - Daymark Health, the company redefining the cancer care experience for patients, providers, and health plans, today announced a $20 million Series A funding round led by Healthier Capital with Blue Venture Fund, with participation from existing investors including Yosemite, Maverick Ventures, and Oncology Ventures.

eNews Park Forest
Sep 25th, 2025
Daymark Health Raises $20M in Series A Funding to Scale Tech-Enabled Cancer Care Platform to Thousands of Patients

PHILADELPHIA, Sept. 25, 2025 /PRNewswire/ - Daymark Health, the company redefining the cancer care experience for patients, providers, and health plans, today announced a $20 million Series A funding round led by Healthier Capital with Blue Venture Fund, with participation from existing investors including Yosemite, Maverick Ventures, and Oncology Ventures.

Endpoints News
Sep 8th, 2025
Daymark Health raises $20M Series A

Cancer care startup Daymark Health has secured $20M in Series A funding, just months after its initial seed round, as reported by Endpoints News.

Behavioral Health Business
Apr 8th, 2025
Daymark Health Raises $11.5M Funding

Daymark Health raised $11.5M for its oncology care collaboration platform, which also offers mental health services. The platform provides symptom care, in-home support, care navigation, social support, and mental health services to 2,500 cancer patients. The funding round was co-led by Maverick Ventures and Yosemite, with care delivered virtually or in-home.